Search Results
Proxy adviser ISS backs three of six MG Capital nominees at HC2: report
By Svea Herbst-Bayliss BOSTON (Reuters) - Proxy adviser Institutional Shareholder Services Inc (ISS) said on Thursday that HC2 Holdings Inc shareholders should vote for the election of three of activi...
Syndicated Content Apr 23, 2020
India's Hetero prices experimental COVID-19 drug remdesivir at $71 per 100 mg vial
BENGALURU (Reuters) - India's Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at 5,400 rupees ($71) per 100-milligram vial, the drugmaker said on Wed...
Syndicated Content Jun 24, 2020
Mylan to launch generic remdesivir version in India at $64 per 100 mg vial
BENGALURU (Reuters) - Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 ...
Syndicated Content Jul 06, 2020
Roche says Lucentis 'port' system as good as injections in eye disease
ZURICH (Reuters) - Roche said a new port delivery system (PDS) for its eye drug Lucentis was as good as monthly injections in blindness-causing macular degeneration, as the Swiss drugmaker aims to ref...
Syndicated Content May 27, 2020
Gilead abandons filgotinib for rheumatoid arthritis in U.S.
(Reuters) - Gilead Sciences Inc said on Tuesday it had decided not to pursue the U.S. Food and Drug Administration's approval of its experimental rheumatoid arthritis treatment, filgotinib, following ...
Syndicated Content Dec 15, 2020
India's Lupin to sell generic COVID-19 drug favipiravir
BENGALURU (Reuters) - Lupin Ltd on Wednesday became the latest Indian drugmaker to launch a version of the antiviral drug favipiravir to treat COVID-19 in the world's third most affected country. A sl...
Syndicated Content Aug 05, 2020
Lilly says antibody drug cuts COVID-19 risk for nursing home residents
By Deena Beasley (Reuters) - A trial of Eli Lilly and Co's antibody drug shows it can cut the risk of COVID-19 by 80% for nursing home residents, the company said on Thursday, although the need for su...
Syndicated Content Jan 21, 2021
India's Sovereign Pharma dispatches first batch of remdesivir to Cipla
BENGALURU (Reuters) - India's Sovereign Pharma said it has dispatched the first batch of generic remdesivir for drugmaker Cipla Ltd, as the country recorded more than 22,000 new coronavirus cases on T...
Syndicated Content Jul 07, 2020
Viking Therapeutics' experimental tablet helps reduce weight in small study
(Reuters) -Viking Therapeutics said on Tuesday its experimental tablet helped reduce weight and was shown to be safe in an early-stage study, sending the company's shares 10% higher in premarket tradi...
Thomson Reuters Mar 26, 2024
No evidence ibuprofen bad for COVID-19 patients: Nurofen-maker
(Reuters) - Nurofen producer Reckitt Benckiser sought to quash warnings against taking the drug on Monday, saying it was not aware of any evidence that the pills' active ingredient ibuprofen adversely...
Syndicated Content Mar 16, 2020